Dec 07, 2016

GenomeWeb Article Offers Insight on GNS-Celgene Deal and Growing Demand for Causal Modeling

GNS Healthcare and Celgene have signed a service and license arrangement that allows the biopharma firm to use GNS Healthcare’s causal machine-learning and simulation platform for applications in drug discovery, clinical development, and commercialization and market access.
Read the full story here.